Bronchonib 100 mg Capsule 10's belongs to the category of 'anti-fibrotic medicine', and it is primarily used to treat idiopathic pulmonary fibrosis (IPF) in adults. IPF is an irreversible disease marked by a progressive decline in lung function. The tissues in the lungs become swollen and scarred over time, due to which it gets difficult to breathe deeply. The scarring makes it hard for the lungs to work properly.

Bronchonib 100 mg Capsule 10's contains 'Nintedanib', which helps reduce the scarring and swelling in the lungs by decreasing the release/activity of naturally occurring growth factors in the body, allowing you to breathe better. Bronchonib 100 mg Capsule 10's helps in slowing down the progress of idiopathic pulmonary fibrosis.

Always use this medicine as your doctor has told you or per the package leaflet. You must keep to your doctor's instructions to get the maximum benefit. In some cases, you may experience common side effects such as nausea, tiredness, diarrhoea, indigestion, loss of appetite, headache, and photosensitivity. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.

Consult your doctor before taking Bronchonib 100 mg Capsule 10's if you are pregnant or breastfeeding. Bronchonib 100 mg Capsule 10's may cause tiredness and dizziness, so drive with caution. Avoid consuming alcohol with Bronchonib 100 mg Capsule 10's as it could lead to increased dizziness. Bronchonib 100 mg Capsule 10's is not recommended for children below 18 years as safety and effectiveness have not been established. Bronchonib 100 mg Capsule 10's is listed as pregnancy category D. Because Bronchonib 100 mg Capsule 10's can cause harm to the fetus, women of childbearing potential should be advised to avoid becoming pregnant while receiving treatment with Bronchonib 100 mg Capsule 10's. Consult your doctor if you are breastfeeding; your doctor will decide whether the Bronchonib 100 mg Capsule 10's can be taken by breastfeeding mothers or not. Keep your doctor informed about your health condition and medicines to rule out any side effects.

Bronchonib 100 mg Capsule 10's is an anti-fibrotic medicine used to treat idiopathic pulmonary fibrosis (IPF) in adults. Bronchonib 100 mg Capsule 10's can help effectively slow the rate of lung function decline by 50%. Bronchonib 100 mg Capsule 10's helps reduce the scarring and swelling in the lungs by decreasing the release/activity of naturally occurring growth factors in the body, allowing you to breathe better. Bronchonib 100 mg Capsule 10's helps in slowing down the progress of idiopathic pulmonary fibrosis.

Do not use Bronchonib 100 mg Capsule 10's if you are allergic to any components present in Bronchonib 100 mg Capsule 10's. Bronchonib 100 mg Capsule 10's is listed as pregnancy category D; because Bronchonib 100 mg Capsule 10's can cause harm to the fetus, women of childbearing potential should be advised to avoid becoming pregnant while receiving treatment with Bronchonib 100 mg Capsule 10's. Consult your doctor if you are breastfeeding; your doctor will decide whether the Bronchonib 100 mg Capsule 10's can be taken by breastfeeding mothers or not. Keep your doctor informed about your health condition and medicines to rule out any side effects. Bronchonib 100 mg Capsule 10's may cause tiredness and dizziness, so drive with caution. Avoid consuming alcohol with Bronchonib 100 mg Capsule 10's as it could lead to increased dizziness. Bronchonib 100 mg Capsule 10's is not recommended for children below 18 years as safety and effectiveness have not been established.

• Regular blood tests and occasional tests of your bone marrow will be carried out to check whether the treatment is working. If it does work, it will usually be taken for life.